Form 4: Colgate-Palmolive Officer's Equity Vesting & Tax Sale

Colgate-Palmolive Chief Growth Officer John Hazlin reported the vesting of performance-based restricted stock units and a subsequent sale of shares to cover tax liabilities.

Summary

• John Hazlin, Chief Growth Officer of Colgate-Palmolive Co. (CL), reported changes in his beneficial ownership.
• On February 23, 2026, 12,803 shares of Common Stock were acquired at a price of $0.0000, representing the vesting of previously granted performance-based restricted stock units (PBRSUs).
• These PBRSUs were earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period.
• Concurrently, 6,117 shares of Common Stock were disposed of at a price of $97.1 per share to cover tax liabilities associated with the PBRSU vesting.
• Following these transactions, John Hazlin directly owns 24,422 shares and indirectly owns 5,452 shares through the Issuer's 401(k) Plan Trustee.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the successful achievement of performance goals by a key executive, offset by a routine tax-related share disposition.

Positives

• The acquisition of 12,803 shares indicates the successful achievement of performance goals by John Hazlin, leading to the vesting of performance-based restricted stock units.
• The vesting of PBRSUs aligns management incentives with shareholder value creation.

Negatives

• The disposition of 6,117 shares, while for tax purposes, reduces the direct ownership stake of the Chief Growth Officer.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to equity compensation vesting and subsequent tax-related sales, are common occurrences across all industries. These transactions reflect standard compensation practices and do not typically signal a change in strategic direction or operational performance, unlike open market purchases or sales.

Comparison to Industry Standards

• Form 4 filings detailing equity compensation vesting and tax-related sales are standard practice for executives in publicly traded companies across various sectors, including consumer staples.
• Similar transactions are routinely observed at peers like Procter & Gamble (PG) or Unilever (UL), where executives receive performance-based awards and sell a portion to cover statutory tax obligations.
• This filing aligns with typical corporate governance and compensation structures for senior leadership.

Related Party Transactions

• The vesting of performance-based restricted stock units and subsequent tax-related share disposition are standard compensation practices between the company and its Chief Growth Officer.

Stakeholder Impact

• Shareholders: The vesting indicates management achieved performance goals, potentially benefiting shareholders. The tax sale is a routine event with minimal direct impact on share price or company operations.
• Management: John Hazlin's compensation structure is being realized, aligning his interests with company performance.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events—vesting of performance-based restricted stock units and a subsequent tax-related sale. It does not provide new fundamental information about Colgate-Palmolive's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and reflect standard corporate governance and compensation practices, thus maintaining a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Colgate-Palmolive, CL, John Hazlin, Chief Growth Officer, SEC Form 4, Insider Trading, Stock Vesting, Restricted Stock Units, PBRSU, Equity Compensation, Tax Withholding